James J. Harding
Memorial Sloan Kettering Cancer Center(US)Cornell University(US)Kettering University(US)Erasmus MC Cancer Institute(NL)Weill Cornell Medicine(US)
Publications by Year
Research Areas
Cholangiocarcinoma and Gallbladder Cancer Studies, Cancer Genomics and Diagnostics, Hepatocellular Carcinoma Treatment and Prognosis, Pancreatic and Hepatic Oncology Research, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients(2017)3,455 cited
- → OncoKB: A Precision Oncology Knowledge Base(2017)2,642 cited
- → HER kinase inhibition in patients with HER2- and HER3-mutant cancers(2018)769 cited
- → CheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC)(2019)644 cited
- → Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients(2022)614 cited
- → Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies(2018)577 cited